GAS5 and inflammatory bowel disease: A 4-week treatment of 19 pediatric IBD patients who were categorized as steroid-resistant (SR), steroid-sensitive (SS), or steroid-dependent (SD) showed that SR and SD patients had higher levels of GAS5 expression than the SS group72.